zk1109913.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC  20549

FORM 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): May 19, 2011 (May 17, 2011)

PLURISTEM THERAPEUTICS INC.
(Exact Name of Registrant as Specified in Its Charter)

Nevada
(State or Other Jurisdiction of Incorporation)

001-31392
  
98-0351734
(Commission File Number)
  
(IRS Employer Identification No.)

MATAM Advanced Technology Park
Building No. 20
Haifa, Israel
  
31905
(Address of Principal Executive Offices)
  
(Zip Code)

011 972 74 710 7171
(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Item 5.07.  Submission of Matters to a Vote of Security Holders.

Pluristem Therapeutics Inc. (the “Company”), held its annual meeting of stockholders on May 17, 2011. Results of stockholder voting at the annual meeting are set forth below.

PROPOSAL NO. 1 — ELECTION OF DIRECTORS.

The stockholders elected the following individuals as Directors of the Company to hold office until the next annual meeting of shareholders and until their successors shall have been duly elected and qualified.

Director Name
  
For
    
Against
    
Abstain
    
Broker Non-Votes
  
                         
Zami Aberman
     12,153,803       1,934,237       83,091       0  
                                 
Israel Ben-Yoram
     13,820,986       17,379       332,766       0  
                                 
Isaac Braun
     13,822,966       15,399       332,766       0  
                                 
Mark Germain
     11,933,374       1,904,991       332,766       0  
                                 
Hava Meretzki
     13,355,179       572,749       243,203       0  
                                 
Shai Pines
     13,884,573       16,999       269,559       0  
                                 
Nachum Rosman
     12,189,990       1,648,415       332,726       0  
                                 
Doron Shorrer
     13,817,847       21,018       332,266       0  

The results reported above are final voting results.
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
PLURISTEM THERAPEUTICS INC.
  
     
Date: May 19, 2011
By:
/s/ Yaky Yanay
  
 
Name:
Yaky Yanay
  
 
Title:
Chief Financial Officer
  

2